课题基金 / 基金详情

DIFFERENTIATION OF MEDULLARY THYROID CARCINOMA CELLS

DIFFERENTIATION OF MEDULLARY THYROID CARCINOMA CELLS
甲状腺髓样癌细胞的分化
批准号:
3191146
负责人:
BARRY D. NELKIN
金额:
$27.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-04-01 至 1996-03-31

项目摘要

项目成果

BARRY D. NELKIN的其他基金

相似基金

相关文献

中文摘要
翻译
本应用程序的研究旨在阐明控制
英文摘要
The studies in this application seek to elucidate the control of neuroendocrine differentiation in normal calcitonin producing thyroid C- cells and their neoplastic counterpart, medullary thyroid carcinoma (MTC). Understanding this control could provide important insight for events in tumor development and progression. Medullary thyroid carcinoma is a good model for this study, since defined stages of progression which involve loss of neuroendocrine differentiation features including capacity for calcitonin production, have been identified. We have developed an in vitro system to study steps of MTC differentiation and progression. MTC cells in culture can be differentiated with respect to many characteristics of normal C-cells including increased calcitonin gene expression, either chemically or by ras oncogene introduction. The current proposal will further characterize these findings, by cell biology, biochemistry, and molecular biology, concentrating on the molecular mechanisms regulating the induced differentiation. The studies proposed will be important not only for identifying the processes which may be involved in neuroendocrine differentiation, and for further elucidating the mechanisms of ras oncogene function in cells. 1. The role of endogenous ras oncogenes in MTC cell differentiation will be investigated by performing several maneuvers to block ras gene function. In addition, the levels of endogenous ras protein expression in normal and hyperplastic C cells, as well as well-differentiated and poorly differentiated MTC, will be examined. Second, it will be determined whether the signal transduction alterations detected following ras gene insertion in MTC cells, are sufficient to induce all or part of the differentiated phenotype mediated by ras. The generality of ras-mediated differentiation in MTC cells will be examined, using two new human MTC cell lines, to determine whether subtypes of MTC exist, differing in their response to ras. Such subtypes may identify other genetic events involved in C-cell differentiation or MTC tumor progression. 2. A ras-responsive transcriptional element in the calcitonin gene will be further characterized, by continuing our isolation of the DNA binding proteins and their genes. Regulation of expression of these proteins, as well as their function in differentiation of MTC and other cells in vitro, and in vivo, will be examined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EXPLOITATION OF RET INHIBITORS FOR TREATMENT OF THYROID CANCER
  • 批准号:
    7300571
  • 项目类别:
  • 资助金额:
    $29.54万
  • 财政年份:
    2007
  • 负责人:
    BARRY D. NELKIN
  • 依托单位:
The Role of CDK5 in Metastasis
  • 批准号:
    7798576
  • 项目类别:
  • 资助金额:
    $35.05万
  • 财政年份:
    2001
  • 负责人:
    BARRY D. NELKIN
  • 依托单位:
Ras/raf/rho in Lung Cancer Growth and Differentiation
  • 批准号:
    6633658
  • 项目类别:
  • 资助金额:
    $33.93万
  • 财政年份:
    2001
  • 负责人:
    BARRY D. NELKIN
  • 依托单位:
The Role of CDK5 in Metastasis
  • 批准号:
    7367520
  • 项目类别:
  • 资助金额:
    $35.05万
  • 财政年份:
    2001
  • 负责人:
    BARRY D. NELKIN
  • 依托单位:
海外基金